{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:25:05Z","timestamp":1791347105670,"version":"4.3.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":365,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54 DK083909"],"award-info":[{"award-number":["U54 DK083909"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Porphyrias are a group of eight metabolic disorders, each resulting from a mutation that affects an enzyme of the heme biosynthetic pathway. Porphyrias are classified as hepatic or erythropoietic, depending upon the site where the gene defect is predominantly expressed. Clinical phenotypes are classified as follows: (1) acute porphyrias with neurovisceral symptoms: acute intermittent porphyria; delta amino-levulinic acid hydratase deficiency porphyria; hereditary coproporphyria; and variegate porphyria and (2) cutaneous porphyrias with skin blistering and photosensitivity: porphyria cutanea tarda; congenital erythropoietic porphyria; hepatoerythropoietic porphyria and both erythropoietic protoporphyrias: autosomal dominant and X-linked. Liver transplantation (LT) may be needed for recurrent and\/or life-threatening acute attack in acute intermittent porphyria or acute liver failure or end-stage chronic liver disease in erythropoietic protoporphyria. LT in acute intermittent porphyria is curative. Erythropoietic protoporphyria patients needing LT should be considered for bone marrow transplantation to achieve cure. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: This article provides an overview of porphyria with diagnostic approaches and management strategies for specific porphyrias and recommendations for LT with indications, pretransplant evaluation, and posttransplant management. (Hepatology 2014;60:1082\u20131089)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.27086","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T17:55:45Z","timestamp":1393264545000},"page":"1082-1089","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":110,"title":["Liver transplantation in the management of porphyria"],"prefix":"10.1097","volume":"60","author":[{"given":"Ashwani K.","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Thapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20250207","doi-asserted-by":"crossref","first-page":"408414","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"Cterminal deletions in the ALAS2 gene lead to gain of function and cause Xlinked dominant protoporphyria without anemia or iron overload.","volume":"83","author":"Whatley","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R2-34-20250207","doi-asserted-by":"crossref","first-page":"439450","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias.","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann Intern Med"},{"key":"R5-34-20250207","doi-asserted-by":"crossref","first-page":"21052110","DOI":"10.1182\/blood.V93.6.2105.406k28_2105_2110","article-title":"Inheritance in erythropoietic protoporphyria: a common wildtype ferrochelatase allelic variant with low expression accounts for clinical manifestation.","volume":"93","author":"Gouya","year":"1999","journal-title":"Blood"},{"key":"R6-34-20250207","first-page":"9196","article-title":"A genotypephenotype correlation between nullallele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria.","volume":"48","author":"Minder","year":"2002","journal-title":"Cell Mol Biol (Noisylegrand)"},{"key":"R7-34-20250207","doi-asserted-by":"crossref","first-page":"196206","DOI":"10.1016\/j.ymgme.2003.07.001","article-title":"Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.","volume":"80","author":"Risheg","year":"2003","journal-title":"Mol Genet Metab"},{"key":"R8-34-20250207","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.2119\/molmed.2012.00340","article-title":"Lossoffunction ferrochelatase and gainoffunction erythroidspecific 5aminolevulinate synthase mutations causing erythropoietic protoporphyria and xlinked protoporphyria in North American patients reveal novel mutations and a high prevalence of Xlinked protoporphyria.","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol Med"},{"key":"R9-34-20250207","first-page":"10091018","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management.","volume":"56","author":"Anstey","year":"2007","journal-title":"Gut"},{"key":"R11-34-20250207","doi-asserted-by":"crossref","first-page":"696705","DOI":"10.1016\/S0016-5085(99)70464-6","article-title":"Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.","volume":"117","author":"Meerman","year":"1999","journal-title":"Gastroenterology"},{"key":"R12-34-20250207","first-page":"744746","article-title":"Structurefunction relationships of protoporphyrininduced liver injury.","volume":"108","author":"Lee","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"R13-34-20250207","doi-asserted-by":"crossref","first-page":"107114","DOI":"10.1172\/JCI1347","article-title":"Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.","volume":"102","author":"Bloomer","year":"1998","journal-title":"J Clin Invest"},{"key":"R14-34-20250207","doi-asserted-by":"crossref","first-page":"958959","DOI":"10.1016\/S0140-6736(94)92314-0","article-title":"Recessive inheritance of erythropoietic protoporphyria with liver failure.","volume":"344","author":"Sarkany","year":"1994","journal-title":"Lancet"},{"key":"R15-34-20250207","first-page":"8389","article-title":"Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.","volume":"48","author":"Chen","year":"2002","journal-title":"Cell Mol Biol (Noisylegrand)"},{"key":"R17-34-20250207","doi-asserted-by":"crossref","first-page":"223229","DOI":"10.1016\/S0009-9120(89)80081-5","article-title":"Hepatobiliary implications and complications in protoporphyria, a 20year study.","volume":"22","author":"Doss","year":"1989","journal-title":"Clin Biochem"},{"key":"R18-34-20250207","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0011-5029(89)90003-5","article-title":"The porphyrias.","volume":"35","author":"Bloomer","year":"1989","journal-title":"Dis Mon"},{"key":"R19-34-20250207","doi-asserted-by":"crossref","first-page":"258259","DOI":"10.1111\/j.1365-2133.1994.tb02913.x","article-title":"Hepatic complications of erythropoietic protoporphyria.","volume":"130","author":"Sarkany","year":"1994","journal-title":"Br J Dermatol"},{"key":"R20-34-20250207","doi-asserted-by":"crossref","first-page":"294302","DOI":"10.1016\/S0016-5085(19)32894-X","article-title":"Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits.","volume":"67","author":"Klatskin","year":"1974","journal-title":"Gastroenterology"},{"key":"R21-34-20250207","first-page":"449457","article-title":"Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment.","volume":"11","author":"Rademakers","year":"1990","journal-title":"Hepatology"},{"key":"R22-34-20250207","doi-asserted-by":"crossref","first-page":"429432","DOI":"10.1001\/archderm.1980.01640280065021","article-title":"Erythropoietic protoporphyria with hepatic cirrhosis.","volume":"116","author":"Wells","year":"1980","journal-title":"Arch Dermatol"},{"key":"R23-34-20250207","doi-asserted-by":"crossref","first-page":"10211026","DOI":"10.1002\/lt.22341","article-title":"Liver transplantation for erythropoietic protoporphyria in Europe.","volume":"17","author":"Wahlin","year":"2011","journal-title":"Liver Transpl"},{"key":"R24-34-20250207","doi-asserted-by":"crossref","first-page":"547553","DOI":"10.1097\/00000658-199211000-00004","article-title":"An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors.","volume":"216","author":"Ozawa","year":"1992","journal-title":"Ann Surg"},{"key":"R25-34-20250207","doi-asserted-by":"crossref","first-page":"817821","DOI":"10.1002\/hep.1840020613","article-title":"Effect of hematin administration to patients with protoporphyria and liver disease.","volume":"2","author":"Bloomer","year":"1982","journal-title":"Hepatology"},{"key":"R26-34-20250207","doi-asserted-by":"crossref","first-page":"922928","DOI":"10.1097\/00007890-199903270-00023","article-title":"The value of intravenous hemealbumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria.","volume":"67","author":"Reichheld","year":"1999","journal-title":"Transplantation"},{"key":"R27-34-20250207","doi-asserted-by":"crossref","first-page":"336341","DOI":"10.1002\/jca.21249","article-title":"Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature.","volume":"27","author":"Pagano","year":"2012","journal-title":"J Clin Apher"},{"key":"R28-34-20250207","doi-asserted-by":"crossref","first-page":"177181","DOI":"10.1016\/0016-5085(88)90627-0","article-title":"Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding.","volume":"94","author":"McCullough","year":"1988","journal-title":"Gastroenterology"},{"key":"R29-34-20250207","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1111\/j.1600-0781.1998.tb00011.x","article-title":"Hepatic complications of erythropoietic protoporphyria.","volume":"14","author":"Gross","year":"1998","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R30-34-20250207","doi-asserted-by":"crossref","first-page":"655657","DOI":"10.1002\/lt.21049","article-title":"Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices.","volume":"13","author":"Eefsen","year":"2007","journal-title":"Liver Transpl"},{"key":"R31-34-20250207","doi-asserted-by":"crossref","first-page":"13401346","DOI":"10.1002\/lt.21527","article-title":"Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria.","volume":"14","author":"Wahlin","year":"2008","journal-title":"Liver Transpl"},{"key":"R32-34-20250207","doi-asserted-by":"crossref","first-page":"e1896e1899","DOI":"10.1542\/peds.2006-0833","article-title":"Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria.","volume":"118","author":"Rand","year":"2006","journal-title":"Pediatrics"},{"key":"R33-34-20250207","doi-asserted-by":"crossref","first-page":"267268","DOI":"10.1111\/j.1540-8191.2005.200438.x","article-title":"Combined valve and coronary surgery in a patient with erythropoietic protoporphyria.","volume":"20","author":"Akinci","year":"2005","journal-title":"J Card Surg"},{"key":"R34-34-20250207","doi-asserted-by":"crossref","first-page":"14041409","DOI":"10.1002\/hep.1840180619","article-title":"Evidence for neurological dysfunction in endstage protoporphyric liver disease.","volume":"18","author":"Rank","year":"1993","journal-title":"Hepatology"},{"key":"R35-34-20250207","doi-asserted-by":"crossref","first-page":"11731175","DOI":"10.1097\/00000542-199910000-00038","article-title":"Photosensitivity and perioperative polyneuropathy complicating orthotopic liver transplantation in a patient with erythropoietic protoporphyria.","volume":"91","author":"Nguyen","year":"1999","journal-title":"Anesthesiology"},{"key":"R36-34-20250207","first-page":"22502251","article-title":"Livingrelated liver transplantation for inborn errors of metabolism.","volume":"26","author":"Tokunaga","year":"1994","journal-title":"Transplant Proc"},{"key":"R37-34-20250207","doi-asserted-by":"crossref","first-page":"393394","DOI":"10.1038\/bmt.2009.132","article-title":"The role for BMT in erythropoietic protoporphyria.","volume":"45","author":"Wahlin","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R38-34-20250207","doi-asserted-by":"crossref","first-page":"471475","DOI":"10.1111\/j.1399-3046.2009.01233.x","article-title":"Delayed immune recovery following sequential orthotopic liver transplantation and haploidentical stem cell transplantation in erythropoietic protoporphyria.","volume":"14","author":"Smiers","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R39-34-20250207","doi-asserted-by":"crossref","first-page":"174179","DOI":"10.1016\/j.jhep.2006.10.004","article-title":"Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis.","volume":"46","author":"Wahlin","year":"2007","journal-title":"J Hepatol"},{"key":"R40-34-20250207","doi-asserted-by":"crossref","first-page":"190196","DOI":"10.1159\/000338354","article-title":"Liver transplantation because of acute liver failure due to heme arginate overdose in a patient with acute intermittent porphyria.","volume":"6","author":"Frei","year":"2012","journal-title":"Case Rep Gastroenterol"},{"key":"R41-34-20250207","doi-asserted-by":"crossref","first-page":"437443","DOI":"10.1111\/j.0954-6820.1978.tb14903.x","article-title":"Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission.","volume":"203","author":"Dhar","year":"1978","journal-title":"Acta Med Scand"},{"key":"R42-34-20250207","doi-asserted-by":"crossref","first-page":"27252729","DOI":"10.1073\/pnas.68.11.2725","article-title":"Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.","volume":"68","author":"Bonkowsky","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-34-20250207","first-page":"12951297","article-title":"Controlled trial of haem arginate in acute hepatic porphyria.","volume":"1","author":"Herrick","year":"1989","journal-title":"Lancet"},{"key":"R45-34-20250207","doi-asserted-by":"crossref","first-page":"14691474","DOI":"10.1001\/archinte.1990.00390190115018","article-title":"A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria.","volume":"150","author":"Anderson","year":"1990","journal-title":"Arch Intern Med"},{"key":"R46-34-20250207","doi-asserted-by":"crossref","first-page":"705706","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria.","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"R47-34-20250207","doi-asserted-by":"crossref","first-page":"195200","DOI":"10.1002\/lt.22345","article-title":"Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.","volume":"18","author":"Dowman","year":"2012","journal-title":"Liver Transpl"},{"key":"R48-34-20250207","doi-asserted-by":"crossref","first-page":"12191227","DOI":"10.1002\/lt.21261","article-title":"Liver transplantation for porphyria: who, when, and how?","volume":"13","author":"Seth","year":"2007","journal-title":"Liver Transpl"},{"key":"R49-34-20250207","doi-asserted-by":"crossref","first-page":"319325","DOI":"10.1046\/j.1365-2796.2000.00743.x","article-title":"Renal symptomatology in patients with acute intermittent porphyria. A populationbased study.","volume":"248","author":"Andersson","year":"2000","journal-title":"J Intern Med"},{"key":"R50-34-20250207","doi-asserted-by":"crossref","first-page":"976980","DOI":"10.1136\/jclinpath-2012-200791","article-title":"Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient followup.","volume":"65","author":"Stewart","year":"2012","journal-title":"J Clin Pathol"},{"key":"R51-34-20250207","first-page":"e18e21","article-title":"Combined liver and kidney transplantation in acute intermittent porphyria.","volume":"23","author":"Wahlin","year":"2010","journal-title":"Transpl Int"},{"key":"R52-34-20250207","doi-asserted-by":"crossref","first-page":"501507","DOI":"10.1136\/jcp.21.4.501","article-title":"Ultrastructural study of the liver in hepatic prophyria.","volume":"21","author":"Jean","year":"1968","journal-title":"J Clin Pathol"},{"key":"R54-34-20250207","first-page":"160163","article-title":"Biochemical and genetic characterization of four cases of hereditary coproporphyria in Spain.","volume":"85","author":"ToFigueras","year":"2005","journal-title":"Mol Genet Metab"},{"key":"R55-34-20250207","doi-asserted-by":"crossref","first-page":"935938","DOI":"10.1002\/lt.20136","article-title":"Recovery from a variegate porphyria by a liver transplantation.","volume":"10","author":"Stojeba","year":"2004","journal-title":"Liver Transpl"},{"key":"R57-34-20250207","first-page":"599606","article-title":"Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency.","volume":"30","author":"Thunell","year":"1992","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"R58-34-20250207","doi-asserted-by":"crossref","first-page":"29722978","DOI":"10.1182\/blood.V97.10.2972","article-title":"Highly heterogeneous nature of deltaaminolevulinate dehydratase (ALAD) deficiencies in ALAD porphyria.","volume":"97","author":"Maruno","year":"2001","journal-title":"Blood"},{"key":"R59-34-20250207","doi-asserted-by":"crossref","first-page":"538545","DOI":"10.1111\/j.1365-2796.2010.02335.x","article-title":"Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15year followup in northern Sweden.","volume":"269","author":"Innala","year":"2011","journal-title":"J Intern Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201409000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:16:47Z","timestamp":1738948607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201409000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27086","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}